血液透析患者聚集性COVID-19的流行病学、临床与免疫特征
BACKGROUND: The outbreak of highly contagious coronavirus disease 2019 (COVID-19) has posed a serious threat to human life and health, especially for those with underlying diseases.…
要点
- 血透患者和医护人员是COVID-19高易感人群,血透中心为高风险区域。
- 多数确诊血透患者症状轻微,未进展为重症肺炎,可能与细胞免疫功能受损有关。
- 血透患者死亡多归因于心脑血管疾病或高钾血症,需重视预防心血管事件。
核心结论
- 血透患者和医护人员是COVID-19高易感人群,血透中心为高风险区域。
- 多数确诊血透患者症状轻微且未进展为重症肺炎,可能与细胞免疫功能受损及无法产生细胞因子风暴有关。
- 应重视预防心血管事件,这可能是疫情对血透患者的间接影响。
研究设计与样本
- 回顾性研究,覆盖武汉大学人民医院血透中心2020年1月14日至3月12日COVID-19全程。
- 纳入230例血透患者和33名医护人员,比较不同患者组与健康人的临床表现和免疫特征。
主要发现
- 3例(8.11%)因重症入住ICU(含2例死亡),多数确诊患者表现为轻度或非呼吸道症状。
- 流式细胞术显示血透患者多种淋巴细胞群显著减少,合并COVID-19的血透患者血清炎症因子降低更明显。
临床怎么用
- 疫情期间应将血透中心和血透患者视为高风险区域和高易感人群,加强防护。
- 对血透合并COVID-19患者,除呼吸道症状外需警惕心脑血管事件和高钾血症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The outbreak of highly contagious coronavirus disease 2019 (COVID-19) has posed a serious threat to human life and health, especially for those with underlying diseases. However, the impact of COVID-19 epidemic on hemodialysis (HD) centers and HD patients has not been reported. METHODS: We reviewed the whole course of the COVID-19 in the HD center of Renmin Hospital, Wuhan University (from January 14, 2020, to March 12, 2020). We compared the clinical manifestation and immune profiles among different patient groups with healthy individuals. RESULTS: Forty-two of 230 HD patients (18.26%) and 4 of 33 medical staff (12.12%) were diagnosed with COVID-19 during the study period. Fifteen HD patients (6.52%), including 10 COVID-19 diagnosed, died. Only 2 deaths of the COVID-19 HD patients were associated with pneumonia/lung failure, others were ascribed to cardiovascular/cerebrovascular diseases or hyperkalemia. Except for 3 patients who were admitted to the intensive care unit for a severe condition (8.11%), including 2 who died, most COVID-19 diagnosed patients presented mild or nonrespiratory symptoms. The flow cytometric analysis of peripheral blood showed that multiple lymphocyte populations in HD patients were significantly decreased. HD patients with COVID-19 even displayed more remarkable reduction of serum inflammatory cytokines than other patients with COVID-19. CONCLUSIONS: Compared with the general population, HD patients and health care professionals are the highly susceptible population and HD centers are high-risk areas during the outbreak. Most HD patients with COVID-19 exhibited mild clinical symptoms and did not progress to severe pneumonia, likely due to the impaired cellular immune function and incapability of mounting cytokine storm. More attention should be paid to prevent cardiovascular events, which may be the collateral impacts of the COVID-19 epidemic on HD patients.
引用
- Ma Y, Diao B, Lv X, et al. Epidemiological, Clinical, and Immunological Features of a Cluster of COVID-19-Contracted Hemodialysis Patients. Kidney Int Rep. 2020. PMID: 32775837. doi:10.1016/j.ekir.2020.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。